407 related articles for article (PubMed ID: 31314757)
1. Onchocerciasis-associated epilepsy in the Democratic Republic of Congo: Clinical description and relationship with microfilarial density.
Siewe Fodjo JN; Mandro M; Mukendi D; Tepage F; Menon S; Nakato S; Nyisi F; Abhafule G; Wonya'rossi D; Anyolito A; Lokonda R; Hotterbeekx A; Colebunders R
PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007300. PubMed ID: 31314757
[TBL] [Abstract][Full Text] [Related]
2. High prevalence of epilepsy in an onchocerciasis endemic health zone in the Democratic Republic of the Congo, despite 14 years of community-directed treatment with ivermectin: A mixed-method assessment.
Mukendi D; Tepage F; Akonda I; Siewe JNF; Rotsaert A; Ndibmun CN; Laudisoit A; Couvreur S; Kabutako B; Menon S; Hotterbeekx A; Colebunders R
Int J Infect Dis; 2019 Feb; 79():187-194. PubMed ID: 30711145
[TBL] [Abstract][Full Text] [Related]
3. Persons with onchocerciasis-associated epilepsy and nodding seizures have a more severe form of epilepsy with more cognitive impairment and higher levels of Onchocerca volvulus infection.
Abd-Elfarag G; Carter JY; Raimon S; Sebit W; Suliman A; Fodjo JNS; Olore PC; Biel KP; Ojok M; Logora MY; Colebunders R
Epileptic Disord; 2020 Jun; 22(3):301-308. PubMed ID: 32540799
[TBL] [Abstract][Full Text] [Related]
4. Ivermectin as an adjuvant to anti-epileptic treatment in persons with onchocerciasis-associated epilepsy: A randomized proof-of-concept clinical trial.
Mandro M; Siewe Fodjo JN; Mukendi D; Dusabimana A; Menon S; Haesendonckx S; Lokonda R; Nakato S; Nyisi F; Abhafule G; Wonya'Rossi D; Jakwong JM; Suykerbuyk P; Meganck J; Hotterbeekx A; Colebunders R
PLoS Negl Trop Dis; 2020 Jan; 14(1):e0007966. PubMed ID: 31923177
[TBL] [Abstract][Full Text] [Related]
5. Onchocerca volvulus as a risk factor for developing epilepsy in onchocerciasis endemic regions in the Democratic Republic of Congo: a case control study.
Mandro M; Suykerbuyk P; Tepage F; Rossy D; Ngave F; Hasan MN; Hotterbeekx A; Mambandu G; Kashama JM; Laudisoit A; Colebunders R
Infect Dis Poverty; 2018 Oct; 7(1):79. PubMed ID: 30293530
[TBL] [Abstract][Full Text] [Related]
6. Clinical presentations of onchocerciasis-associated epilepsy (OAE) in Cameroon.
Siewe JFN; Ngarka L; Tatah G; Mengnjo MK; Nfor LN; Chokote ES; Boullé C; Nkouonlack C; Dema F; Nkoro GA; Njamnshi WY; Tabah EN; Zoung-Kanyi Bissek AC; Colebunders R; Njamnshi AK
Epilepsy Behav; 2019 Jan; 90():70-78. PubMed ID: 30513438
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics of onchocerciasis-associated epilepsy in villages in Maridi County, Republic of South Sudan.
Colebunders R; Abd-Elfarag G; Carter JY; Olore PC; Puok K; Menon S; Fodjo Siewe JN; Bhattacharyya S; Ojok M; Lako R; Logora MY
Seizure; 2018 Nov; 62():108-115. PubMed ID: 30340162
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of epilepsy in onchocerciasis endemic health areas in Democratic Republic of the Congo.
Lenaerts E; Mandro M; Mukendi D; Suykerbuyk P; Dolo H; Wonya'Rossi D; Ngave F; Ensoy-Musoro C; Laudisoit A; Hotterbeekx A; Colebunders R
Infect Dis Poverty; 2018 Aug; 7(1):68. PubMed ID: 30064504
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for epilepsy in Bas-Uélé Province, Democratic Republic of the Congo: a case-control study.
Colebunders R; Mandro M; Mokili JL; Mucinya G; Mambandu G; Pfarr K; Reiter-Owona I; Hoerauf A; Tepage F; Levick B; Begon M; Laudisoit A
Int J Infect Dis; 2016 Aug; 49():1-8. PubMed ID: 27210267
[TBL] [Abstract][Full Text] [Related]
10. High prevalence of epilepsy in onchocerciasis endemic regions in the Democratic Republic of the Congo.
Levick B; Laudisoit A; Tepage F; Ensoy-Musoro C; Mandro M; Bonareri Osoro C; Suykerbuyk P; Kashama JM; Komba M; Tagoto A; Falay D; Begon M; Colebunders R
PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005732. PubMed ID: 28708828
[TBL] [Abstract][Full Text] [Related]
11. Clinical presentation of epilepsy in six villages in an onchocerciasis endemic area in Mahenge, Tanzania.
Bhwana D; Mmbando BP; Dekker MC; Mnacho M; Kakorozya A; Matuja W; Makunde WH; Weckhuysen S; Colebunders R
Epileptic Disord; 2019 Oct; 21(5):425-435. PubMed ID: 31649005
[TBL] [Abstract][Full Text] [Related]
12. Effect of Ivermectin Treatment on the Frequency of Seizures in Persons with Epilepsy Infected with
Dusabimana A; Tsebeni Wafula S; Raimon SJ; Fodjo JNS; Bhwana D; Tepage F; Abd-Elfarag G; Hotterbeekx A; Abrams S; Colebunders R
Pathogens; 2020 Dec; 10(1):. PubMed ID: 33396221
[TBL] [Abstract][Full Text] [Related]
13. Ivermectin treatment response in two rural villages with a high prevalence of onchocerciasis and epilepsy, Mahenge Tanzania.
Bhwana D; Mmbando BP; Dusabimana A; Mhina A; Challe DP; Fodjo JNS; Makunde WH; Colebunders R
Afr Health Sci; 2022 Sep; 22(3):607-616. PubMed ID: 36910370
[TBL] [Abstract][Full Text] [Related]
14. The impact of ivermectin on onchocerciasis in villages co-endemic for lymphatic filariasis in an area of onchocerciasis recrudescence in Burkina Faso.
Nikièma AS; Koala L; Sondo AK; Post RJ; Paré AB; Kafando CM; Kambiré RS; Sow B; Bougouma C; Dabiré RK; Traoré S
PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009117. PubMed ID: 33647010
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of onchocerciasis-associated epilepsy in the Mbam and Sanaga river valleys of Cameroon: impact of more than 13 years of ivermectin.
Siewe Fodjo JN; Tatah G; Tabah EN; Ngarka L; Nfor LN; Chokote SE; Mengnjo MK; Dema F; Sitouok AT; Nkoro G; Ntone FE; Bissek AZ; Chesnais CB; Boussinesq M; Colebunders R; Njamnshi AK
Infect Dis Poverty; 2018 Dec; 7(1):114. PubMed ID: 30501640
[TBL] [Abstract][Full Text] [Related]
16. Population dynamics of onchocerca volvulus microfilariae in human host after six years of drug control.
Opara KN; Fagbemi BO
J Vector Borne Dis; 2008 Mar; 45(1):29-37. PubMed ID: 18399314
[TBL] [Abstract][Full Text] [Related]
17. Onchocerciasis-associated epilepsy: an update and future perspectives.
Hadermann A; Amaral LJ; Van Cutsem G; Siewe Fodjo JN; Colebunders R
Trends Parasitol; 2023 Feb; 39(2):126-138. PubMed ID: 36528471
[TBL] [Abstract][Full Text] [Related]
18. Single dose moxidectin versus ivermectin for Onchocerca volvulus infection in Ghana, Liberia, and the Democratic Republic of the Congo: a randomised, controlled, double-blind phase 3 trial.
Opoku NO; Bakajika DK; Kanza EM; Howard H; Mambandu GL; Nyathirombo A; Nigo MM; Kasonia K; Masembe SL; Mumbere M; Kataliko K; Larbelee JP; Kpawor M; Bolay KM; Bolay F; Asare S; Attah SK; Olipoh G; Vaillant M; Halleux CM; Kuesel AC
Lancet; 2018 Oct; 392(10154):1207-1216. PubMed ID: 29361335
[TBL] [Abstract][Full Text] [Related]
19. The role of Onchocerca volvulus in the development of epilepsy in a rural area of Tanzania.
König R; Nassri A; Meindl M; Matuja W; Kidunda AR; Siegmund V; Bretzel G; Löscher T; Jilek-Aall L; Schmutzhard E; Winkler AS
Parasitology; 2010 Sep; 137(10):1559-68. PubMed ID: 20388236
[TBL] [Abstract][Full Text] [Related]
20. Low prevalence of epilepsy and onchocerciasis after more than 20 years of ivermectin treatment in the Imo River Basin in Nigeria.
Siewe JNF; Ukaga CN; Nwazor EO; Nwoke MO; Nwokeji MC; Onuoha BC; Nwanjor SO; Okeke J; Osahor K; Chimechefulam L; Ogomaka AI; Amaechi AA; Ezenwa CI; Ezike MN; Ikpeama C; Nwachukwu O; Eriama-Joseph AI; Nwoke BEB; Colebunders R
Infect Dis Poverty; 2019 Jan; 8(1):8. PubMed ID: 30670093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
